BayFirst Financial Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BayFirst Financial Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.94M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $12.60M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $5.70M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($349.0K) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $24.62M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $12.70M | Mar 31, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $285.30M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $390.53M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $454.80M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $440.25M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $495.39M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($107.82M) | Mar 31, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $300.0K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.69M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.58M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.06M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $13.12M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $3.05M | Mar 31, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.12B | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $938.90M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $917.10M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.54B | Mar 31, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.02B | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $847.01M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $820.81M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.47B | Mar 31, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.57M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $110.92M | Mar 27, 2026 |
| FY2025 | Dec 31, 2023 | $100.71M | Mar 27, 2026 |
| FY2024 | Dec 31, 2022 | $91.88M | Mar 25, 2025 |
| FY2023 | Dec 31, 2021 | $96.29M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $71.07M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $51.33M | Mar 31, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.76M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $44.13M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $34.40M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $33.48M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $35.95M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $13.39M | Mar 31, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $206.98M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $77.79M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $58.39M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $66.05M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $109.73M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $55.38M | Mar 31, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 6 | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 3 | Mar 31, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 5 | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 3 | Mar 31, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.11M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 4.13M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 4.11M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 4.04M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 3.98M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 3.49M | Mar 31, 2022 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $663.0K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.32M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.31M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.29M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.06M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $915.0K | Mar 31, 2022 |